Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H20N2O2 |
| Molecular Weight | 320.385 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(N1CCN(CC2=CC=CC=C2)CC1)C3=CC4=C(O3)C=CC=C4
InChI
InChIKey=SRIJFPBZWUFLFD-UHFFFAOYSA-N
InChI=1S/C20H20N2O2/c23-20(19-14-17-8-4-5-9-18(17)24-19)22-12-10-21(11-13-22)15-16-6-2-1-3-7-16/h1-9,14H,10-13,15H2
| Molecular Formula | C20H20N2O2 |
| Molecular Weight | 320.385 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4089015
Befuraline, given in oral doses of between 100 and 300 mg/day improved the HDRS total score and the cognitive disturbances to a significant extent (p less than 0.01) after the first week of the treatment.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:17:31 GMT 2025
by
admin
on
Mon Mar 31 18:17:31 GMT 2025
|
| Record UNII |
787AQ35GHR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
||
|
NCI_THESAURUS |
C744
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BEFURALINE
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
68664
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
100000086115
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
41717-30-0
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
C015697
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
C72720
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL1076256
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
787AQ35GHR
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
DTXSID2046206
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
3851
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY | |||
|
SUB05683MIG
Created by
admin on Mon Mar 31 18:17:31 GMT 2025 , Edited by admin on Mon Mar 31 18:17:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |